Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA’s Role and Compassionate Use: Senate Hearing Raises Old Questions In New Context

This article was originally published in RPM Report

Executive Summary

FDA is subject to Congressional oversight from many different committees in the House and Senate. But Homeland Security isn’t usually one of them. Maybe that’s why some of the testimony felt about 15 years out of date.


Related Content

Sarepta's Eteplirsen Is Centerpiece Of Senate Hearing On Expanded Access
Another Chance to Make Priority Review Vouchers Work


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts